Gene Expression Analysis Market Worth $4.3 Billion by 2018 - Prominent Player - Affymetrix, Inc. (U.S.), Roche Diagnostics (Switzerland), Agilent Technologies (U.S.)

Gene Expression Analysis Market by Technology (DNA Microarray, Real-Time PCR, Next Generation Sequencing), Consumables (DNA Chips, Reagents), Services (Gene Profiling, Bioinformatics, Data Analysis Software) & Applications] - Global Forecast to 2018


Dallas, TX -- (SBWIRE) -- 12/09/2014 -- The global gene expression market is segmented into instrumentation, consumables, and services. Based on technologies, the gene expression analysis instrumentation market is further segmented into DNA microarrays, real-time PCR, next-generation sequencing, and others. The consumables market is further categorized into DNA chips and reagents, while the services market is sub-segmented into gene expression profiling services, bioinformatics solutions, data analysis software, and others.

Based on applications, the global market is broadly categorized into diagnostics, drug discovery, biomarkers, and others. Based on geography, the market is divided into North America, Europe, Asia, and the Rest of World (RoW). North America is the largest market, followed by Europe and Asia. However, the Asian market is slated to grow at the highest rate over the next five years.

Speak To Analyst :

Over the years, the demand for gene expression has increased significantly owing to the increasing research on diseases like cancer, Alzheimer's, and Parkinson's. The technological advancements in the field of gene expression are expected to drive the global market in the coming years. Furthermore, advancements in sequencing platforms have also led to the decrease in the cost of sequencing. This is expected to boost the market as the amount of sequencing is likely to increase. The other factors that are driving the growth of the global market are the favorable funding scenario worldwide and increasing usage of gene expression analysis for medical research and diagnosis.

Interest in Report:

Another pivotal factor that drives the growth of the market is the increasing attention towards personalized medicine. The use of personalized medicine is believed to yield better results for treatments undertaken. Therefore, pharmaceutical companies are increasingly investing in personalized medicine research. However, the shortage of geneticists and high cost of equipment are factors hindering the market.

About MarketsandMarkets
MarketsandMarkets is world's No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.

M&M's flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.

We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.

Mr. Rohans
North - Dominion Plaza
17304 Preston Road
Suite 800, Dallas, TX 75252
Tel: 888-600-6441
Visit MarketsandMarkets Blog
Connect with us on LinkedIn